Cost-effective resource apportionment technologies suitable for facilitating therapies

• US 20120265547A1
• Filed: 04/14/2011
• Published: 10/18/2012
• Est. Priority Date: 04/14/2011
• Status: Abandoned Application

• Current Assignee: The Invention Science Fund II, L.L.C. (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Hwang, Eun Young, Hyde, Roderick A., Ishikawa, Muriel Y., Kare, Jordin T., Rivet, Dennis J., Sweeney, Elizabeth A., Tegreene, Clarence T., Wood, Victoria Y.H., Wood, Lowell L. Jr.
• Application Number:
  US13/066,445
• Publication Number:
  US 20120265547A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G06Q 30/0207 Discounts or incentives, e.g. coupons or rebates
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients

Abstract

Configuration technologies for apportioning resources and communicating indications of potential or actual incentives based on one or more measurements or other objective indications that therapeutic components have been administered to an individual, other attributes of the therapeutic components or the individual, or other such determinants. Techniques for apportioning resources cost-effectively (between providers and other parties, e.g.) and for facilitating or handling implementations thereof or output therefrom.

Claims

1. A resource apportionment method comprising:

invoking circuitry for obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual, a component of the artificial incentive being an artificial incentive to a provider of the therapeutic component; and

including the indication of the artificial incentive in or with a message.

3. The resource apportionment method of claim 1, in which the invoking circuitry for obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

invoking circuitry for conditioning the artificial incentive upon compliance with a regimen that includes a plasma lipid-modifying material component as the therapeutic component.

2. (canceled)

4-50. -50. (canceled)

51. A resource apportionment system comprising:

means for obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual, a component of the artificial incentive being an artificial incentive to a provider of the therapeutic component; and

means for including the indication of the artificial incentive in or with a message.

77. The resource apportionment system of claim 51, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

means for determining the artificial incentive by obtaining a physical attribute of the individual.

80. The resource apportionment system of claim 77, in which the means for determining the artificial incentive by obtaining a physical attribute of the individual comprises:

means for determining the artificial incentive by obtaining a gender of or an age of the individual as the physical attribute of the individual.

52-76. -76. (canceled)

78-79. -79. (canceled)

81-94. -94. (canceled)

95. A resource apportionment system comprising:

circuitry for obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual, a component of the artificial incentive being an artificial incentive to a provider of the therapeutic component; and

circuitry for including the indication of the artificial incentive in or with a message.

99. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for conditioning the artificial incentive upon compliance with a regimen that includes at least one respiratory or physical therapy session.

100. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for determining the artificial incentive to have a value partly based on a value of the therapeutic component and partly based on a physical attribute of a putative recipient of the therapeutic component.

107. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for conditioning the artificial incentive upon compliance with a regimen that includes an anti-infective component of the therapeutic component.

108. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for determining the artificial incentive as a linear function of a value of the therapeutic component.

112. The resource apportionment system of claim 95, in which the including the indication of the artificial incentive in or with a message comprises:

circuitry for authorizing a transfer of one or more resources into an account of a recipient as a component of the artificial incentive.

114. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for conditioning the artificial incentive upon an actuation in a vessel.

120. The resource apportionment system of claim 95, in which the including the indication of the artificial incentive in or with a message comprises:

circuitry for obtaining a size of the artificial incentive in response to a pattern of enrollment.

121. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for determining the artificial incentive by obtaining a physical attribute of the individual.

123. The resource apportionment system of claim 121, in which the circuitry for determining the artificial incentive by obtaining a physical attribute of the individual comprises:

circuitry for determining the artificial incentive by obtaining a health status as the physical attribute of the individual.

127. The resource apportionment system of claim 95, in which the including the indication of the artificial incentive in or with a message comprises:

circuitry for selecting a recipient of a notification of the artificial incentive in response to a received message.

140. The resource apportionment system of claim 95, further comprising:

a vessel containing the therapeutic component; and

administration detection logic configured to detect one or more device-detectable auditory indications of a movement of the vessel containing the therapeutic component.

142. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for obtaining a signal from a compliance-sensitive dispensing device.

143. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for receiving an indication from a test of a bodily fluid of the individual after the dispensing device administers the therapeutic component to the individual.

144. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for receiving the indication of the artificial incentive from a site that has apparently received the category of the therapeutic component and an indication of the dispensing device administering the therapeutic component to the individual.

147. The resource apportionment system of claim 95, in which the obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for detecting the dispensing device administering the therapeutic component to the individual via injection, the therapeutic component being a bioactive material.

151. The resource apportionment system of claim 95, further comprising:

a vessel containing the therapeutic component and having an actuator.

189. The resource apportionment system of claim 95, in which the circuitry for obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for obtaining a test result of a sample extracted from the individual as the objective indication that the therapeutic component has been administered to the portion of the individual;

circuitry for conditioning the artificial incentive upon compliance with a regimen that includes a plasma lipid-modifying material component as the therapeutic component; and

circuitry for receiving an indication from a test of a bodily fluid of the individual after the dispensing device administers the therapeutic component to the individual, the indication from the test of the bodily fluid of the individual being another objective indication that the therapeutic component has been administered to the portion of the individual.

190. The resource apportionment system of claim 95, in which the circuitry for obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for conditioning the artificial incentive upon compliance with a regimen that includes at least one respiratory or physical therapy session;

circuitry for determining the artificial incentive to have a value partly based on a value of the therapeutic component and partly based on a physical attribute of a putative recipient of the therapeutic component, the putative recipient being the individual; and

circuitry for obtaining an indication of when at least a portion of a vessel moved as the objective indication that the therapeutic component has been administered to the portion of the individual.

191. The resource apportionment system of claim 95, in which the circuitry for obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual comprises:

circuitry for conditioning the artificial incentive upon compliance with a regimen that includes an anti-infective component of the therapeutic component;

circuitry for determining the artificial incentive as a linear function of a value of the therapeutic component; and

circuitry for obtaining an indication that a vessel has been ingested as the objective indication that the therapeutic component has been administered to the portion of the individual.

192. The resource apportionment system of claim 95, in which the circuitry for including the indication of the artificial incentive in or with a message comprises:

circuitry for presenting the message to the provider of the therapeutic component, the therapeutic component being a bioactive material, and another message to another provider, the other message being indicative of the artificial incentive;

circuitry for manifesting an improvement in a reputation of the provider of the therapeutic component, the improvement being the component of the artificial incentive; and

circuitry for transferring one or more credits to the provider of the therapeutic component as another component of the artificial incentive in response to an indication that the therapeutic component was administered.

193. The resource apportionment system of claim 95, in which the circuitry for including the indication of the artificial incentive in or with a message comprises:

circuitry for obtaining a size of the artificial incentive in response to a pattern of enrollment;

circuitry for transmitting the indication of the artificial incentive to the provider of the therapeutic component, the indication of the artificial incentive being a first notification of the artificial incentive;

circuitry for selecting a recipient of a second notification of the artificial incentive in response to a received message; and

circuitry for authorizing a transfer of one or more resources into an account of the recipient as the component of the artificial incentive, the recipient not being the provider of the artificial component.

96-98. -98. (canceled)

101-106. -106. (canceled)

109-111. -111. (canceled)

113. (canceled)

115-119. -119. (canceled)

122. (canceled)

124-126. -126. (canceled)

128-139. -139. (canceled)

141. (canceled)

145-146. -146. (canceled)

148-150. -150. (canceled)

152. (canceled)

153. An article of manufacture comprising:

one or more physical media configured to bear a device-detectable implementation of a method including at least

obtaining an indication of an artificial incentive at least partly based on an objective indication that a therapeutic component has been administered to a portion of an individual, a component of the artificial incentive being an artificial incentive to a provider of the therapeutic component; and

including the indication of the artificial incentive in or with a message.

179. The article of manufacture of claim 153, in which a portion of the one or more physical media comprises:

one or more signal-bearing media configured to transmit one or more instructions for transmitting the indication of the artificial incentive to another individual.

154-178. -178. (canceled)

180-188. -188. (canceled)